Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7558629

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
3,059,000,000 JPY
5,123,000,000 JPY
5,007,000,000 JPY
4,046,000,000 JPY
Non-operating income
Non-operating income
93,000,000 JPY
799,000,000 JPY
677,000,000 JPY
83,000,000 JPY
Non-operating expenses
Non-operating expenses
177,000,000 JPY
94,000,000 JPY
115,000,000 JPY
170,000,000 JPY
Ordinary profit (loss)
2,975,000,000 JPY
5,827,000,000 JPY
5,569,000,000 JPY
3,960,000,000 JPY
Extraordinary income
Extraordinary income
1,979,000,000 JPY
0 JPY
Extraordinary losses
Extraordinary losses
0 JPY
900,000,000 JPY
352,000,000 JPY
0 JPY
Profit (loss) before income taxes
2,974,000,000 JPY
6,906,000,000 JPY
5,216,000,000 JPY
3,959,000,000 JPY
Income taxes - current
-25,000,000 JPY
2,462,000,000 JPY
1,630,000,000 JPY
45,000,000 JPY
Income taxes - deferred
-5,000,000 JPY
-279,000,000 JPY
-346,000,000 JPY
-5,000,000 JPY
Profit (loss)
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
3,005,000,000 JPY
4,723,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,932,000,000 JPY
3,919,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.